FREEZE DRIED INJECTABLE DRUG PRODUCT DEVELOPMENT: SELECTION OF NON FUNCTIONAL ADDITIVES

  • Article Retracted
  • Mehta Priti

Abstract

Article Retracted from Publication due to copyright violence

Downloads

Download data is not yet available.

References

1. Nema S, Brendel RJ. Excipients and their role in approved injectable products: current usage and future directions. PDA J Pharm Sci Technol 2011;65(3):287-332.
2. British Pharmacopeia, Parenteral Preparations. In British Pharmacopoeia: Stationary office London; 1999. p. 1575.
3. European Pharmacopeia, Parenteral Preparations. European Pharmacopoeia. Council of Europe, Strasbourg. 2009;6th edition: 1765.
4. Robertson MI. Regulatory issues with excipients. Int J Pharm 1999;187:273–6.
5. Jennings TA. Effect of formulation on lyophilization, part 1. IVD Technology Magazine, 1997.
6. Pikal MJ. Freeze-drying of proteins. Part II: Formulation selection. Bio Pharm1990;3:26-30.
7. Crowe JH, Hoekstra FA, Crowe LM. Anhydrobiosis. Annu Rev Physiol 1992;54:579–99.
8. Crowe LM, Reid DS, Crowe JH. Is trehalose special for preservingdry materials?Biophys. J 1996;71:2087–93.
9. Townsend MW, Deluca MEPP. Use of Lyoprotectants in the Freeze-Drying of a Model Protein, Ribonuclease A. PDA J of Pharm Sci Technology 1988;42 (6):190-9.
10. Richard LR, Krishnan SK, William JC. Development of Stable Lyophilized Protein Drug Products. Current Pharm Biotechnology 2012;13(3):471-96.
11. Frank KBA. Understanding Lyophilization Formulation Development. Pharm Tech Lyophilization 2004;10-18.
12. Meister E, Ellnain M, Gieseler H, Aaps. Collapse temperature measurement by freeze-dry microscopy and transferability to freeze drying processes: inluence of solute concentration on collapse behavior and effect on cycle design. Meeting and Exposition Oct 29Nov San. Antonio Texas USA 2006;2
13. Amin K, Dannenfelser RM, Zielinski J, Wang B. Lyophilization of polyethylene glycol mixtures. J Pharm Sci 2004;93(9):2244-9.
14. Chang BS, Randall CS. Use of subambient thermal analysis to optimize protein lyophilization. Cryobiology 1992;29:632-56.
15. Mac Kenzie AP. The physico-chemical basis of the freeze drying process. Dev Biol Std 1976;36:51-67.
16. Franks F. Freeze drying: from empiricism to predictability. Cryo-Letters 1990;11:93-110.
17. Her LM, Nail SL. Measurement of glass transition temperatures of freeze-concentrated solutes by differential scanning calorimetry. Pharm Res 1994;11:54-9.
18. MacKenzie AP. Basic principles of freeze drying for pharmaceuticals. Bull Par Drug Assoc 1966;20:101-29.
19. Bellows RJ, King CJ. Freeze drying of aqueous solutions: maximum allowable operating temperature. Cryobiology 1972;9:559-61.
20. Shalaev EY, Kanev AN. Study of the solid-liquid state diagram of the water-glycine-sucrose system. Cryobiology 1994;31:374-82.
21. Pikal MJ, Freeze drying, in Swarbrick J, Boylan JC. (eds):Encyclopedia of Pharmaceutical Technology, Marcel Dekker Inc. New York NY; 1992;6:275-303.
22. Trissel LA. Handbook on injectable drugs, American society of Hospital Pharmacists, Inc. 8th edition. 1994.
23. Montvale NJ. Physicians Desk Reference. Medical Economics Company Incorporation 53rd edition. 1999.
24. Shalaev EY. The impact of buffer on processing and stability of freeze-dried dosage forms. Am Pharm Rev 2005;8:80-7.
25. Shalaev EY, Wang W, Gatin LA. Rational choice of excipients for use in lyophi ized formulations. in McNally EJ and Hastedt JE (eds):Protein formulation and delivery. Informa Healthcare New York, NY, 2008;175;197-217.
Statistics
835 Views | 2964 Downloads
How to Cite
Retracted, A., and M. Priti. “FREEZE DRIED INJECTABLE DRUG PRODUCT DEVELOPMENT: SELECTION OF NON FUNCTIONAL ADDITIVES”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 6, no. 9, 1, pp. 3-7, https://innovareacademics.in/journals/index.php/ijpps/article/view/3204.
Section
Review Article(s)